Physics in pandemic

Online teaching & learning with virtual reality, whether effective or not, is gaining ground in masses due to many reasons like i) lack of good (knowledge, sincere and hardworking) teachers, ii) insufficient laboratory space and shortage of resources for good experiments, iii) students disinterest in spending specified time in theory & practical classes and iv) availability of online knowledge resources. Students are giving more importance … Continue reading Physics in pandemic

Three new oral anti-diabetics drugs in India- co-marketed by Cipla & Boehringer Ingelheim

Cipla Limited and Boehringer Ingelheim India Pvt. Ltd. have announced their partnership in India to co-market three new oral anti-diabetics drugs Oboravo® (Empagliflozin), Oboravo Met® (Empagliflozin+Metformin) and Tiptengio® (Empagliflozin+Linagliptin) As per the International Diabetes Federation, India is home to 77 million adults aged between 20 and 79 years with diabetes, ranking second behind China; and is poised to reach 134.2 million patients by 2045. Fortunately, … Continue reading Three new oral anti-diabetics drugs in India- co-marketed by Cipla & Boehringer Ingelheim

M.P.Council of Science & Technology Invited Recruitment Application for RA & JRF

MP Council of Science & Technology, Bhopal invited application for “Research Associates (RA), and Junior Research Fellows (JRF)” .Rrecruitment of “Research Associates (RA) – Fellowship amount Rs. 30,000/- pm fixed and Junior Research Fellows (JRF) – Fellowship amount Rs. 20,000/- pm fixed” for its present and future projects. Candidates with following qualifications may apply in prescribed format given at portal “Job Opportunity@MPCOST” at Council’s website (www.mpcost.gov.in). … Continue reading M.P.Council of Science & Technology Invited Recruitment Application for RA & JRF

Bio Safety Level-3 Advanced Virology Lab for COVID 19-NBRI

Advanced Virology Lab” for testing of COVID-19 has established in The National Botanical Research Institute (NBRI), Lucknow. The facility has been developed based on the guidelines of the Indian Council Medical Research (ICMR), the World Health Organisation (WHO), and the Ministry of Health and Family Welfare. Bio Safety Level (BSL) 3 level facility According to ICMR guidelines, BSL2 level facility is recommended for COVID-19 but … Continue reading Bio Safety Level-3 Advanced Virology Lab for COVID 19-NBRI

सीमैप के हर्बल कॉस्मेटिक्स का होगा मार्केट प्रोडक्शन

केंद्रीय औषधीय एवं सगंध पौधा संस्थान (सीमैप) द्वारा विकसित हर्बल कॉस्मेटिक उत्पादों के व्यावसायिक उत्पादन के लिए एक निजी कंपनी के साथ करार किया गया है। इस समझौते के तहत सीमैप द्वारा विकसित किए गए हर्बल उत्पादों- रिलैक्सोमैप, पेनज़ा, पेनछू, फ्लोमॉप और एक्ने प्रिवेंटिव फेसवॉश बनाने की तकनीक विकसित की गई है। औषधीय तथा सगंध पौधों के क्षेत्र में शोध एवं विकास के लिए कार्यरत … Continue reading सीमैप के हर्बल कॉस्मेटिक्स का होगा मार्केट प्रोडक्शन

CSIR-Summer Research Training Programme (CSIR-SRTP-2020)

Jorhat-based CSIR-NEIST got the mandate from DG, CSIR to organize and coordinate a country-wide CSIR-Summer Research Training Programme (CSIR-SRTP-2020). The North East Institute of Science and Technology (NEIST) is working towards ameliorating the stagnancy created in the academic scenario of the nation due to COVID-19 pandemic. online programme (CSIR-SRTP-2020) is going to be discharged through the faculties and mentors from 38 CSIR laboratories spread across the … Continue reading CSIR-Summer Research Training Programme (CSIR-SRTP-2020)

Umifenovir can be a safe, efficacious, affordable drug against COVID-19- CDRI, India

CSIR-Central Drug Research Institute(CDRI) Lucknow, has received permission for carrying out Phase III randomised, Double blind, Placebo controlled trial of efficacy, safety and tolerability of antiviral drug Umifenovir. The Phase III Clinical Trials will be carried out at King George’s Medical University (KGMU), Dr. Ram Manohar Lohia Institute of Medical Sciences (RMLIMS) and ERA’s Lucknow Medical College & Hospital, Lucknow. Umifenovir is mainly used for … Continue reading Umifenovir can be a safe, efficacious, affordable drug against COVID-19- CDRI, India

Identified Immune Response Protection Against COVID-19

Covid 19 infected Patients suffering from severe respiratory symptoms can rapidly generate an immune response in the form of virus-attacking T cells, suggests a new study which may lead to new vaccine development strategies against COVID-19. The study, published in the journal Science Immunology, assessed T cells from 10 COVID-19 patients under intensive care treatment. According to the researchers, including those from the University of … Continue reading Identified Immune Response Protection Against COVID-19

Covifor is the first generic brand of Remdesivir

The approval of ‘COVIFOR’, the generic of Remdesivir by Drugs Controller General of India (DCGI), Hetero Healthcare Limited, a group company of Hetero is set to deliver the first set of 20,000 vials in two equal lots of 10,000 each, one of which, will be immediately supplied to Hyderabad, Delhi, Gujarat, Tamil Nadu, Mumbai and other parts of Maharashtra; while the other lot will be supplied to … Continue reading Covifor is the first generic brand of Remdesivir

DST India sets up joint science communication forum

Joint Science Communication Forum in a view to facilitate interaction, cooperation, and coordination amongst various public sector science communication institutions and agencies is initiated via The Department of Science & Technology (DST). The Forum brings together science communication efforts spread across various institutions and can help adoption of a common policy and best practices at a wider scale, ultimately aiming towards a national science communication framework. … Continue reading DST India sets up joint science communication forum